The Hypertrophic Cardiomyopathy (HCM) Program at University of Utah Health is one of the nation’s few programs for comprehensive HCM evaluation and management. Our multidisciplinary team works ...

For patients with hypertrophic cardiomyopathy that doesn’t improve with standard therapy, surgery may be the next choice. In France, a new study was conducted to compare the incidence of in-hospital ...

Treating patients with HCM is guided by how severe symptoms are, whether a patient has any risk factors for sudden cardiac death, and whether a patient has cardiac arrhythmias and other associated ...

Data showed that approximately 1 in 20 patients hospitalized for HC either have or will have a GIB event during their hospitalization. In the GIB group, those affected were more likely to be women, of ...

Hypertrophic cardiomyopathy (HCM) is a primary disease of cardiac muscle characterized by a thickening of the left ventricular wall and often predominantly affecting the interventricular septum. This ...